Pelago Bioscience
Pre-clinicalPelago Bioscience delivers CETSA®-powered target engagement assays to validate drug–target interactions in live cells throughout drug discovery.
Founded
2016
Focus
Drug DeliveryProteomics
About
Pelago Bioscience delivers CETSA®-powered target engagement assays to validate drug–target interactions in live cells throughout drug discovery.
Funding History
2Total raised: $7.2M
Series A$6MIndustrifondenJun 15, 2021
Seed$1.2MUppsala University InvestJun 15, 2018
Company Info
TypePrivate
Founded2016
LocationSolna, Sweden
StagePre-clinical
Contact
SIMILAR COMPANIES
Basic Genomics
Pre-clinical · Stockholm
2A Pharma
Phase 1 · Stockholm
Abliva
Pre-clinical · Lund
Affibody
Phase 1 · Solna
Alligator Bioscience
Phase 1 · Lund
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile